What is Dyne Therapeutics, Inc.'s interest paid?

Dyne Therapeutics, Inc. (DYN) reported interest paid of $3.63M in Q1 2026.

What does interest paid mean?

Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.

Dyne Therapeutics, Inc. DYN Interest Paid

Interest Paid at other companies

Ionis PharmaceuticalsIONS

$90K-2.2%

Arrowhead ResearchARWR

$4.75K—

PTC TherapeuticsPTCT

$2.16M0.0%

Scholar RockSRRK

$2.37M+57.9%

Catalyst PharmaceuticalCPRX

$140K+35.9%

CytokineticsCYTK

$1.59M-83.6%

Other financials

Income statement

See full

Operating income-$125.3M-2.4%

Net income-$120.9M-4.8%

EPS (diluted)-$0.73+30.5%

Balance sheet

See full

Cash & equivalents$753.1M+59.5%

Total debt$168.7M+623%

Total equity$865.1M+29.3%

Total assets$1.1B+49.8%

Cash flow

See full

Operating cash flow-$144.9M-36.9%

CapEx$221.0K-77.5%

Free cash flow-$145.1M-35.8%

Valuation

See full

Market cap$3.35B+153%

Returns & leverage

See full

Return on equity-58.9%-4.4pp

Debt / equity0.2×+0.2×

Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s interest paid?: Dyne Therapeutics, Inc. (DYN) reported interest paid of $3.63M in Q1 2026.
What does interest paid mean?: Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.